Current location - Trademark Inquiry Complete Network - Tian Tian Fund - What's the difference between the national essential drugs list and the medical insurance list?
What's the difference between the national essential drugs list and the medical insurance list?
1, the scope of use is different: the national essential drugs list considers both clinical needs and public health needs, including immune vaccines, anti-AIDS and tuberculosis drugs. The medical insurance catalogue refers to the drugs that are necessary to ensure the clinical treatment of employees and are included in the basic medical insurance coverage, which are divided into Class A and Class B.

2. Different payment methods: The national list of essential drugs needs to adopt various methods to ensure effective and continuous supply. The government guarantees production and supply through fixed-point and reserve methods, and provides high-level guarantee through special financial funds or medical insurance funds to improve patients' affordability of essential drugs.

The drugs in the medical insurance catalogue are different according to different payment methods, and Class A drugs are basically unified throughout the country, which can ensure the basic needs of clinical treatment. The expenses of such drugs are included in the payment scope of the basic medical insurance fund, and the expenses are paid according to the basic medical insurance payment standard.

Class B drugs refer to drugs that the basic medical insurance fund has a certain ability to pay. These drugs are paid by employees according to a certain proportion, and then included in the coverage of the basic medical insurance fund, and paid according to the basic medical insurance payment standard.

3. Different emphases: The National Essential Drugs List is the first-line drug used in clinic. With the deepening of the reform of medical insurance payment methods, such as payment by disease type and total prepayment, the list of essential drugs has a stronger guiding role from the perspective of ensuring supply and guiding clinical rational drug use.

Extended data:

I. Background:

With the transformation from planned economy to market economy in China, it is urgent to establish and improve the social security system including social medical insurance. 199865438+February, China promulgated the Decision on Establishing the Basic Medical Insurance System for Urban Workers, which marked the establishment of a new medical security system.

In order to ensure employees' basic medical drugs and reasonably control the drug costs, the Interim Measures for the Administration of the Drug Use Scope of Basic Medical Insurance for Urban Employees was promulgated in May of the following year, which stipulated that the drug use scope of basic medical insurance should be managed by formulating the drug list of basic medical insurance.

In 2000, the national basic medical insurance drug list was born, and the supporting measures for the reform of China medical insurance system were officially launched. On this basis, in September 2004, the Ministry of Labor and Social Security promulgated the National Drug List of Basic Medical Insurance and Industrial Injury Insurance.

Second, the characteristics:

The government will take various measures to ensure effective and continuous supply of essential drugs listed in the national essential drugs list, ensure production and supply through fixed-point and reserve, and provide high-level protection through special financial funds or inclusion in medical insurance funds to improve patients' affordability of essential drugs.

Baidu Encyclopedia-National Essential Drugs Catalogue

Baidu encyclopedia-basic medical insurance drugs